Baird Initiates Coverage of Omada Health (OMDA) with Neutral Recommendation
Fintel reports that on September 5, 2025, Baird initiated coverage of Omada Health (NasdaqGS:OMDA) with a Neutral recommendation.
Analyst Price Forecast Suggests 19.18% Upside
As of September 4, 2025, the average one-year price target for Omada Health is $28.27/share. The forecasts range from a low of $24.24 to a high of $32.55. The average price target represents an increase of 19.18% from its latest reported closing price of $23.72 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual non-GAAP EPS is -0.58.
What are Other Shareholders Doing?

AH Capital Management, L.L.C. holds 4,615K shares representing 8.01% ownership of the company.
NVP Associates holds 2,531K shares representing 4.40% ownership of the company.
Perceptive Advisors holds 2,426K shares representing 4.21% ownership of the company.
Loomis Sayles & Co L P holds 1,090K shares representing 1.89% ownership of the company.
Rock Springs Capital Management holds 920K shares representing 1.60% ownership of the company.